Better Marijuana Stock: OrganiGram vs. Curaleaf
Most cannabis companies have done well amid the coronavirus pandemic thanks to regular demand for marijuana, which is behaving more and more like a consumer good. U.S. pot companies in particular have soared this year. Curaleaf Holdings (OTC: CURLF) is one example, having experienced revenue growth and improving profit margins since January. Meanwhile, challenges for Canadian counterparts remain. Last year's headwinds, which included regulatory delays and a thriving black market, continue to take a toll on the Canadian market. OrganiGram Holdings' (NASDAQ: OGI) performance is proof of that.
OrganiGram is smaller than Curaleaf, sporting a market cap of $221 million compared to Curaleaf's cap of $3.8 billion. Shares of Curaleaf are up 13.8% this year, while Organigram is down a sobering 53.8%. The Horizons Marijuana Life Sciences ETF declined by 28% over the same period. Let's take a look at which among these two cannabis stocks is the more hopeful investment.
Image source: Getty Images.
Source Fool.com
